

- 8
- Episodes
- 2026
- First episode
About Deep dive - Health - My Meds
Deep dive explores the day to day issues faced by individuals and health care professionals in the UK and the rest of the world and finds solutions whiles dissecting the ease of access and usefulness of those tools
- Publisher
- Deep dive health - My Meds
- Category
- technology
- Language
- en
- Explicit
- No
- First episode
- 9 Feb 2026
- Latest episode
- 10 Feb 2026
Latest episodes
8 episodes in the feed.

10 Feb 2026
“Why the BNF App Is No Longer Enough – and How My Meds UK Fixes the Problem”
Section 1 – The original purpose vs modern reality 1. What was the BNF originally designed to do, and why was that sufficient 20–30 years ago? 2. How has modern prescribing complexity outgrown a generalist reference model? 3. Can a single summarised entry realistically support today’s polypharmacy, comorbidity, and high-risk prescribing environments? ⸻ Section 2 – Coverage gaps and oversimplification 4. Why does “general guidance” become a clinical risk when nuance matters? 5. How many licensed medicines, formulations, and presentations are missing or insufficiently detailed in the BNF? 6. What happens when clinicians must leave the BNF to check SmPCs, PILs, or MHRA updates elsewhere? ⸻ Section 3 – Workflow friction and unsafe shortcuts 7. How does limited depth force clinicians to rely on memory, habit, or assumptions? 8. Why does fragmented information increase prescribing error rather than reduce it? 9. Is a reference tool still fit for purpose if it requires constant cross-checking outside the app? ⸻ Section 4 – The dangerous shift toward AI without guardrails 10. Why are clinicians increasingly turning to general AI tools instead of traditional references? 11. What are the risks of AI systems that pull information from forums, international sources, or non-UK regulatory frameworks? 12. How do hallucinations and unverifiable answers create silent patient-safety risks? ⸻ Section 5 – Regulation, jurisdiction, and accuracy 13. Why does UK-specific regulation matter when prescribing medicines? 14. What happens when advice is based on US, EU, or anecdotal practice rather than MHRA-approved data? 15. How can a clinician confidently defend a decision if the source is not regulator-anchored? ⸻ Section 6 – What My Meds UK does differently 16. What does it mean to cover literally every licensed drug rather than a curated subset? 17. How does grounding every answer in SmPC-level data eliminate hallucinations entirely? 18. Why does depth, not brevity, actually save time in clinical decision-making? ⸻ Section 7 – The future of safe prescribing 19. What should a modern medication intelligence platform look like in 2026 and beyond? 20. How does My Meds UK shift healthcare professionals from “best guess” to defensible certainty? ⸻ 📚 Podcast Table of Contents (Episode-Ready) Episode Title: “Beyond the BNF: Why UK Prescribing Needs a New Standard” 1. Introduction – The prescribing world has changed 2. What the BNF does well—and where it stops 3. The danger of generalised drug summaries 4. Real-world prescribing complexity 5. Missing depth, missing safety 6. Why clinicians are leaving traditional references 7. AI answers: fast, confident, and sometimes wrong 8. Hallucinations, jurisdiction errors, and hidden risk 9. Why regulation-anchored data matters 10. What “complete drug coverage” actually means 11. Live walkthrough: the same question in BNF vs My Meds UK 12. Eliminating fake information in healthcare 13. How My Meds UK supports safer decisions 14. The future of medication intelligence 15. Final message: accuracy is not optional

10 Feb 2026
Vaccines – Evidence, Protection, and the Truth Behind the Myths
1. Introduction – Why vaccines matter more than ever 2. How vaccines work inside the immune system 3. Types of vaccines and why choice matters 4. Diseases vaccines have pushed back or eliminated 5. Understanding effectiveness and protection 6. Vaccine safety: trials, monitoring, and transparency 7. Side effects explained without fear 8. Debunking the most common vaccine myths 9. Ingredients and why context matters 10. Vaccines through childhood, adulthood, and ageing 11. Protecting those who cannot be vaccinated 12. Risk vs benefit: putting numbers into perspective 13. How My Meds UK reveals the full evidence 14. Final takeaway: science, trust, and public health

10 Feb 2026
Antibiotics – When “Just in Case” Becomes Dangerous
"Can I just have a course of antibiotics... just in case?" We have all heard it. Many of us have asked it. But treating antibiotics like a "safety net" for the common cold isn't just clinically useless-it is a biological gamble. In this deep-dive episode of My Meds Uk, we challenge the culture of precautionary prescribing. We explore why antibiotics are powerful tools that demand respect, not routine fixes that can be popped like vitamins. In this video, we uncover the risks you rarely see on the label: Bacteria vs. Virus: Why taking antibiotics for a viral infection (like the flu) creates zero benefit but 100% risk. The Invisible Enemy (AMR): We explain Antimicrobial Resistance simply. Learn why misuse affects everyone-even people who have never taken antibiotics themselves. Gut Health & C. Diff: It's not just "an upset stomach." We discuss how antibiotics disrupt your microbiome and the risk of life-threatening Clostridioides difficile infections. Hidden Dangers: From tendon rupture to QT prolongation and neuropathy-we reveal the serious adverse effects associated with specific antibiotic classes. Dangerous Cocktails: Did you know that alcohol, certain foods, or your daily antidepressant can drastically alter antibiotic toxicity? We break down the interactions you need to know. Stop guessing. Start checking. Don't rely on old habits. Use the My Meds UK app to check the SmPC (Summary of Product Characteristics) for your specific antibiotic. Verify the resistance warnings, check interactions with your other meds, and understand the real risks before you swallow that pill. Download My Meds UK: - Get it on the App Store: https://apps.apple.com/gb/app/mymeds-uk/id6753774595 Chapters: - The "Just in Case" Trap - Bacteria vs.Viruses: The Fatal Misunderstanding - Antimicrobial Resistance (AMR) Explained - The Gut Microbiome & C. Difficile - Serious Risks: Tendon Rupture & Neuropathy - Interactions: Alcohol & Anticoagulants - How to Check Your Risks on My Meds UK #MyMedsUK #Antibiotics #AMR #PublicHealth #AntibioticResistance #PatientSafety #DigitalHealth #NHS

10 Feb 2026
The Biological Gamble of Ozempic and Mounjaro
It is the most talked-about pharmaceutical trend of the decade. From Hollywood celebrities to your "For You" page, everyone seems to be talking about the "miracle" weight loss jabs. But beyond the viral transformation videos and the headlines, what is actually happening inside your body when you take these drugs? In this eye-opening episode of the My Meds UK podcast, we strip away the social media hype to reveal the uncomfortable biological truths behind Ozempic (semaglutide) and Mounjaro (tirzepatide). We explore the journey of these medicines from their origins as diabetes treatments to their explosion as lifestyle weight-loss tools. Are they a scientific breakthrough for obesity, or are patients unwittingly participating in a massive biological experiment? In this episode, we uncover: • The Mechanism of Control: We explain the pharmacological difference between GLP-1 receptor agonists and dual GIP/GLP-1 agonists. How do they actually hijack your hunger signaling to make you forget to eat? • The "Silent" Side Effects: Beyond the common nausea and "Ozempic face," we dig into the official SmPC data regarding severe dehydration, electrolyte imbalances, and the risks that land patients in the hospital. • Organ Impact: We tackle the serious red flags that influencers rarely mention-specifically the documented risks of pancreatitis, gallbladder disease, and the thyroid tumor warnings found in regulatory documents. • The Rebound Effect: Is weight regain a failure of willpower, or a predictable biological response? We discuss what happens physiologically when the injections stop. • Mental & Emotional Shifts: We explore the psychological impact of chemically suppressed appetite and the emerging reports on mood changes and anhedonia. • The "Off-Label" Reality: We clarify what it means to use these drugs "off-label" in the UK and why relying on an influencer for dosage advice is a dangerous game. Why this matters: This isn't about fear-mongering; it's about informed consent. Before you or a loved one considers these treatments, you need to know the difference between a "miracle" and a medical intervention with real biological costs. Don't guess the risks. Check the facts. Use the My Meds UK app to read the official Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for these medicines yourself. Verify the side effects, check interactions, and get answers grounded in UK regulatory data-not algorithms. Follow Us: LinkedIn: My Meds Ltd Instagram: @MyMedsltd Disclaimer: This podcast explores pharmaceutical data for educational purposes only. My Meds UK does not provide medical advice, diagnosis, or treatment. Always consult your doctor or pharmacist before starting or stopping any medication.https://www.mymedsltd.com (https://www.mymedsltd.com)

9 Feb 2026
My Meds UK: Disrupting the threshold of uncertainty
My Meds UK is a mobile application and digital platform designed to provide people in Britain with official, reliable medication data sourced directly from the MHRA. The service features a comprehensive searchable database of patient information leaflets and clinical documents, supplemented by AI-powered assistance to answer drug-related questions in simple terms. Users can benefit from safety tools such as drug interaction checkers, dosage reminders, and NHS prescription scanning to manage their health regimes more effectively. The company prioritises rigorous data security, employing enterprise-grade encryption and adhering to UK GDPR standards to protect sensitive medical history. Available on the iOS App Store, the platform offers a free basic tier alongside a Pro subscription for advanced safety and monitoring features. Ultimately, the startup aims to reduce medication errors by centralising fragmented pharmaceutical information into one trustworthy, mobile-first experience.

9 Feb 2026
My Meds UK: The medication cabinet in every home
Open your bathroom cabinet. What do you see? Likely a clutter of half-empty boxes, lost paper leaflets, and expired prescriptions. In a world where we digitize our banking, our travel, and our shopping, why is our medication management still stuck in the analogue age? In this episode, we explore how My Meds UK is transforming the chaotic physical medicine cabinet into a smart, streamlined, and safe digital experience. We sit down with Founder Isaac-Xavier Dale to discuss the company's ambitious vision: to become the default medication companion for every household in the United Kingdom. We discuss why "Googling your symptoms" is dangerous and how My Meds UK provides a safer alternative by putting official MHRA data directly into the hands of patients, parents, and carers. In this episode, we unpack: • The Digital Cabinet: Say goodbye to squinting at tiny text on crumpled paper leaflets. We explain how the app allows you to carry the official Patient Information Leaflets (PILs) and Summaries of Product Characteristics (SPCs) for every UK-licensed medicine in your pocket-completely for free. • The "Roger" Revolution: Meet your new family health assistant. We demo Roger, the Al Medication Guide that answers your specific questions (like "Can I drive while taking this?") using only verified UK regulatory data, ensuring you get answers that are accurate, not hallucinatory. • Family Safety & Polypharmacy: For the millions of households managing multiple prescriptions, the risks are real. We dive into the Interaction Checker, a Pro feature that acts as a safety net, instantly analyzing the risks of mixing drugs like blood pressure medication with common painkillers. • Adherence is Key: Missed doses cost the NHS millions and harm patient health. We look at how the app's Smart Reminders differ from a standard alarm clock, offering compliance history and detailed dosage tracking. • A Vault, Not a Sieve: We discuss the "Security that lets you sleep easy." Unlike free web searches that track your data, My Meds UK uses enterprise-grade encryption (TLS 1.3, AES-256) and Apple Sign-In to ensure your health data remains yours. As the team says: "You are NOT the product" Whether you are a busy parent, a carer for an elderly relative, or just someone trying to keep their health organized, this episode proves why My Meds UK deserves a spot on your home screen. • Free Database Access: Search the full MHRA library of medicines without a subscription. • Pro Features: Unlock unlimited Al Chat with Roger, Interaction Checks, and Compliance History (7-Day Free Trial available). • Privacy: GDPR Compliant and backed by Vanta security monitoring. Download the App: Start building your digital cabinet today on the Apple App Store. Connect with Us: Linkedin: My Meds Ltd Instagram: @MyMedsltd Disclaimer: My Meds UK provides information based on official MHRA data but does not provide medical advice, diagnosis, or treatment. Always consult your doctor or pharmacist before making decisions about your medication.

9 Feb 2026
My Meds UK: Explore and Learn
What do we know about this new company?

9 Feb 2026
My Meds UK: medication information at your fingertips!
Have you ever searched for a medication online, only to be bombarded with confusing US-based dosages, terrifying forums, or medical jargon you couldn't decipher? In the UK alone, medication errors cost the NHS an estimated £3.9 billion every year—often because patients simply don't have access to the right information when they need it most. In this inaugural 24-minute episode, we sit down with Isaac-Xavier Dale, the Founder and CEO of My Meds UK, to discuss why it is time to "demystify" medical information. We take a deep dive into the launch of the new My Meds UK app—a tool designed to be the "single source of truth" for British patients. Isaac shares the journey from concept to the App Store, explaining why relying on general search engines for health advice is a thing of the past. - My Meds Ltd Company Overview and Terms of Servi... In this episode, we cover: • The "Dr. Google" Problem: Why the internet is broken for UK patients. We discuss the dangers of fragmented data and how US-centric search results confuse patients about UK-licensed medicines. • Meet Roger ® : We introduce "Roger," the app's Al Medication Guide. Learn how My Meds UK combined cutting-edge Artificial Intelligence with official MHRA regulatory documents to create a chatbot that answers your questions in plain English —without hallucinating fake medical advice. • The Polypharmacy Solution: For those managing multiple prescriptions, we discuss the "Interaction Checker." We explore how the app helps you analyze potential conflicts between drugs like Ramipril and Ibuprofen in seconds, rather than guessing the risks. • Privacy as a Priority: In an era where data is the new oil, My Meds UK takes a different stand. We discuss the company's "Security that lets you sleep easy" philosophy, ensuring that your health data is never sold to advertisers. As Isaac puts it: "You are NOT the product". • The "Spaceship" Moment: Isaac shares his personal reflection on shipping the app, comparing the launch to "stepping out of a spaceship" to watch his creation simplify everyday lives.
Host of Deep dive - Health - My Meds?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.